BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2017
View Archived Issues
INmune Bio licenses checkpoint inhibitor from Xencor
Read More
Genentech initiates phase I study of RO-7171009 for GA secondary to AMD
Read More
Plexxikon initiates phase Ib/IIa study of PLX-2853 in advanced malignancies
Read More
LIBD and VA collaborate in PTSD
Read More
Athera initiates phase IIa trial of PC-mAB in patients with arterial inflammation
Read More
Astellas, Mitsubishi Tanabe and Daiichi Sankyo establish JOINUS drug repositioning program
Read More
Izun reports phase II data on IZN-6N4 in oral mucositis
Read More
FDA grants priority review to Gilotrif sNDA
Read More
Recursion in research collaboration agreement with Takeda
Read More
Safety and pharmacokinetics of ETX-2514 determined in phase I trial
Read More
DNA Zika virus vaccine GLS-5700 safe and immunogenic in healthy subjects
Read More
FDA issues complete response letter for AcelRx's Dsuvia NDA
Read More
Janssen submits NDA for apalutamide for non-metastatic castration-resistant prostate cancer
Read More
Natural killer cell levels and activitation are altered in scrub typhus patients
Read More
GlaxoSmithKline describes novel integrin antagonists
Read More
Japan Science and Technology Agency patents beta-amyloid aggregation inhibitors
Read More
University of Minnesota presents new indole and indazole derivatives
Read More
Novel apelin receptor agonists synthesized at Bristol-Myers Squibb
Read More
CSIR develops novel silicon-containing quinolines
Read More
Investment deal to support University of Toronto start-up Janpix
Read More
Brexpiprazole begins phase III trials to treat manic episodes associated with bipolar I disorder
Read More
Symproic launched in U.S.
Read More
Phase IIa results for VDA-1102 in actinic keratosis support progression to phase IIb
Read More
Elsalys Biotech acquires Leukotac rights from Jazz
Read More
Ardelyx's T3MPO-2 phase III trial of tenapanor for IBS-C meets endpoints
Read More
Merck & Co. will not make regulatory filings for anacetrapib
Read More
Katholieke Universiteit Leuven, Janssen patent dengue virus replication inhibitors
Read More
FDA advisory committee recommends approval of Luxturna gene therapy
Read More
NCI grant supports VLP Therapeutics' development of VLP vaccine-based cancer immunotherapy
Read More
Final study results show 71% success rate for WTX-101 in Wilson's disease
Read More
